SDC1 and pancreatic intraductal papillary-mucinous neoplasm: SDC1 and ITGA2 are among the DEGs identified in IPMN and PDAC, and monitoring their expression is of great value in predicting whether IPMN will develop into PDAC with a poorer prognosis.